Retrieve available abstracts of 10 articles: HTML format
Single Articles
April 2025
GUO X, Li S Bone metastases of prostate cancer: Molecular mechanisms, targeted diagnosis and
targeted therapy (Review).
Oncol Rep. 2025;53:46. PubMedAbstract available
February 2025
YANG C, Wang L, Gong C, Lv D, et al Antibody?drug conjugates in prostate cancer: Emerging strategies to enhance
therapeutic index and current clinical landscape (Review).
Oncol Rep. 2025;53:21. PubMedAbstract available
November 2024
ZHOU Y, Ji Z, Yan W, Zhou Z, et al [Retracted] Tetramethylpyrazine inhibits prostate cancer progression by
downregulation of forkhead box M1.
Oncol Rep. 2024;52:152. PubMedAbstract available
October 2024
NOURUZI S, Johnson F, Kumar S, Sivak O, et al Targeting adenocarcinoma and enzalutamide?resistant prostate cancer using the
novel anti?androgen inhibitor ADA?308.
Oncol Rep. 2024;52:132. PubMedAbstract available
June 2024
LIU Y, Qin Z, Yang K, Liu R, et al [Corrigendum] Cripto?1 promotes epithelial?mesenchymal transition in prostate
cancer via Wnt/beta?catenin signaling.
Oncol Rep. 2024;51:75. PubMedAbstract available
PAN J, Tong F, Ren N, Ren L, et al Role of N(6)?methyladenosine in the pathogenesis, diagnosis and treatment of
prostate cancer (Review).
Oncol Rep. 2024;51:88. PubMedAbstract available
May 2024
HSIA YJ, Lin ZM, Zhang T, Chou TC, et al Butyrate increases methylglyoxal production through regulation of the
JAK2/Stat3/Nrf2/Glo1 pathway in castration?resistant prostate cancer cells.
Oncol Rep. 2024;51:71. PubMedAbstract available
March 2024
PARAJULI KR, Jung Y, Taichman RS Abscisic acid signaling through LANCL2 and PPARgamma induces activation of p38MAPK
resulting in dormancy of prostate cancer metastatic cells.
Oncol Rep. 2024;51:39. PubMedAbstract available
January 2024
LEE DY, Chun JN, So I, Jeon JH, et al Oncogenic role of FOXM1 in human prostate cancer (Review).
Oncol Rep. 2024;51:15. PubMedAbstract available
December 2023
LEE DY, Lee S, Kim YS, Park S, et al Cyclosporin A inhibits prostate cancer growth through suppression of E2F8
transcription factor in a MELK?dependent manner.
Oncol Rep. 2023;50:218. PubMedAbstract available